Literature DB >> 9236743

Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis.

T D McHugh1, T Bathgate, J Mangan, J D Johnson, R E Holliman, P D Butcher.   

Abstract

Current serological tests do not discriminate between asymptomatic latent Toxoplasma gondii infection and reactivating toxoplasmosis, but timely therapeutic intervention before the development of symptoms would lead to major reductions in morbidity and permanent disability. This study developed a new enzyme-linked immunosorbent assay (ELISA) for antibody to T. gondii tissue cyst antigens and screened tissue cyst antigens by Western blot analysis to test the hypothesis that antibody recognition of T. gondii tissue cyst-derived antigen is a good indicator of reactivation disease. A total of 187 sera was tested by Sabin-Feldman dye test and tissue cyst ELISA, AIDS patients and patients with ocular disease were considered separately, as the exposure to parasite antigens may be different in these two groups. The dye test did not discriminate between immunocompetent and immunocompromised T. gondii seropositive patients or between active and quiescent toxoplasmosis. Tissue cyst ELISA demonstrated a raised specific antibody response in immunocompetent T. gondii seropositive patients and in quiescent HIV positive sera. These data support th view that the tissue cyst population is in a state of dynamic equilibrium. It is proposed that, in the immunocompetent host, tissue cyst development and rupture are under some degree of immune control, but that in the immunocompromised host this equilibrium is disturbed and reactivation disease results. Data from patients with reactivating ocular toxoplasmosis demonstrate that tissue cyst-specific antibody levels are not different in active and quiescent disease and indeed they are not significantly different from immunocompetent T. gondii seronegative sera. In the Western blot analysis of 57 HIV positive patient sera, eight antigens (65, 57, 49, 47, 36, 28, 26 and 18 kDa) were consistently recognised by one third or more of the sera tested, but no single antigen was diagnostic of quiescent or active toxoplasmosis. It is concluded that tissue cyst-derived antigens are not a reliable serological marker of reactivating toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236743     DOI: 10.1099/00222615-46-7-587

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Management of toxoplasmic retinochoroiditis during pregnancy, postpartum period and lactation: clinical observations.

Authors:  Joanna Brydak-Godowska; Joanna Moneta-Wielgoś; Dariusz Kęcik; Piotr Karol Borkowski
Journal:  Med Sci Monit       Date:  2015-02-25

2.  Do pregnancy, postpartum period and lactation predispose to recurrent toxoplasmic retinochoroiditis?

Authors:  Joanna Brydak-Godowska; Piotr Karol Borkowski; Daniel Rabczenko; Joanna Moneta-Wielgoś; Dariusz Kęcik
Journal:  Med Sci Monit       Date:  2015-02-23

Review 3.  Anti-Toxoplasma gondii IgM Long Persistence: What Are the Underlying Mechanisms?

Authors:  José Antonio Vargas-Villavicencio; Irma Cañedo-Solares; Dolores Correa
Journal:  Microorganisms       Date:  2022-08-17

4.  The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.

Authors:  Piotr K Borkowski; Joanna Brydak-Godowska; Wojciech Basiak; Karolina Świtaj; Hanna Żarnowska-Prymek; Maria Olszyńska-Krowicka; Piotr Kajfasz; Daniel Rabczenko
Journal:  PLoS Negl Trop Dis       Date:  2016-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.